diphenhydramine has been researched along with 2019 Novel Coronavirus Disease in 2 studies
Diphenhydramine: A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.
diphenhydramine : An ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug.
antitussive : An agent that suppresses cough. Antitussives have a central or a peripheral action on the cough reflex, or a combination of both. Compare with expectorants, which are considered to increase the volume of secretions in the respiratory tract, so facilitating their removal by ciliary action and coughing, and mucolytics, which decrease the viscosity of mucus, facilitating its removal by ciliary action and expectoration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berkowitz, RL | 1 |
| Bluhm, AP | 1 |
| Knox, GW | 1 |
| McCurdy, CR | 1 |
| Ostrov, DA | 1 |
| Norris, MH | 1 |
| Grewal, E | 1 |
| Sutarjono, B | 1 |
| Mohammed, I | 1 |
2 other studies available for diphenhydramine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Sigma Receptor Ligands Prevent COVID Mortality In Vivo: Implications for Future Therapeutics.
Topics: Animals; Antiviral Agents; COVID-19; Diphenhydramine; Lactoferrin; Ligands; Mice; Receptors, sigma; | 2023 |
Angioedema, ACE inhibitor and COVID-19.
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Anti-Allergic Agents; Benzazepines; Betacorona | 2020 |